BMC Proceedings
1753-6561
Cơ quản chủ quản: BioMed Central Ltd.
Lĩnh vực:
Medicine (miscellaneous)Biochemistry, Genetics and Molecular Biology (miscellaneous)
Các bài báo tiêu biểu
Short-chain sphingolipids for enhanced cellular uptake of liposome-encapsulated amphiphilic anti-cancer drugs
Tập 4 - Trang 1-1 - 2010
Cr(VI)-induced malignant transformation of a bronchial epithelial cell line association with altered mitochondria and bioenergetic phenotypes
Tập 4 Số 2 - Trang 1-1 - 2010
Joint analysis of multiple blood pressure phenotypes in GAW19 data by using a multivariate rare-variant association test
Tập 10 Số S7 - 2016
Testing rare variants for hypertension using family-based tests with different weighting schemes
Tập 10 - Trang 233-237 - 2016
Next-generation sequencing technology makes directly testing rare variants possible. However, existing statistical methods to detect common variants may not be optimal for testing rare variants because of allelic heterogeneity as well as the extreme rarity of individual variants. Recently, several statistical methods to detect associations of rare variants were developed, including population-based and family-based methods. Compared with population-based methods, family-based methods have more power and can prevent bias induced by population substructure. Both population-based and family-based methods for rare variant association studies are essentially testing the effect of a weighted combination of variants or its function. How to model the weights is critical for the testing power because the number of observations for any given rare variant is small and the multiple-test correction is more stringent for rare variants. We propose 4 weighting schemes for the family-based rare variants test (FBAT-v) to test for the effects of both rare and common variants across the genome. Applying FBAT-v with the proposed weighting schemes on the Genetic Analysis Workshop 19 family data indicates that the power of FBAT-v can be comparatively enhanced in most circumstances.